A detailed history of Catalina Capital Group, LLC transactions in Adagene Inc. stock. As of the latest transaction made, Catalina Capital Group, LLC holds 12,737 shares of ADAG stock, worth $28,148. This represents 0.01% of its overall portfolio holdings.

Number of Shares
12,737
Previous 16,752 23.97%
Holding current value
$28,148
Previous $51.3 Million 44.86%
% of portfolio
0.01%
Previous 0.02%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 30, 2024

SELL
$2.12 - $3.49 $8,511 - $14,012
-4,015 Reduced 23.97%
12,737 $28.3 Million
Q2 2024

Jul 24, 2024

BUY
$2.12 - $3.24 $35,514 - $54,276
16,752 New
16,752 $51.3 Million

Others Institutions Holding ADAG

About Adagene Inc.


  • Ticker ADAG
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 43,423,200
  • Market Cap $96M
  • Description
  • Adagene Inc., a clinical stage biopharmaceutical company, engages in the research, development, and production of monoclonal antibody drugs for cancers. The company's product candidates include ADG106, a human ligand-blocking agonistic anti-CD137 monoclonal antibodies (mAbs) that is in Phase 1b/2 clinical trials for the treatment advanced solid ...
More about ADAG
Track This Portfolio

Track Catalina Capital Group, LLC Portfolio

Follow Catalina Capital Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Catalina Capital Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Catalina Capital Group, LLC with notifications on news.